Guido Lancman

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Respiratory Syndrome Coronavirus

Multiple Myeloma

Peritoneal Dialysis

Top Venues

Annals of hematology

Blood cancer discovery

Cancer research

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Guido Lancman, Kian Parsa, Krzysztof Kotlarz, Lisa Avery, Alaina Lurie, Alex Lieberman-Cribbin, Hearn Jay Cho, Samir S Parekh, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J Sanchez, Santiago Thibaud, Sundar Jagannath, Ajai Chari
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies. Blood cancer discovery (2023)
Anup Joseph Devasia, Guido Lancman, A Keith Stewart
A Landmark Paper That Introduced Proteasome Inhibition in Myeloma. Cancer research 83 (19) (2023)
Guido Lancman, Erin Moshier, Hearn Jay Cho, Samir Parekh, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa Sanchez, Sundar Jagannath, Ajai Chari
Trial designs and endpoints for immune therapies in multiple myeloma. American journal of hematology (2022)
Hannah Levavi, Guido Lancman, Janice L Gabrilove
Impact of rituximab on COVID-19 outcomes. Annals of hematology 100 (11) (2021)
Guido Lancman, Dahniel L Sastow, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir S Parekh, Shambavi Richard, Joshua Richter, Larysa Sanchez, Ajai Chari
Bispecific Antibodies in Multiple Myeloma: Present and Future. Blood cancer discovery 2 (5) (2021)
Guido Lancman, Bridget K Marcellino, Santiago Thibaud, Kevin Troy
Plasma hemoglobin in COVID-19: authors' reply. Annals of hematology 100 (8) (2020)
Guido Lancman, Bridget K Marcellino, Santiago Thibaud, Kevin Troy
Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19. Annals of hematology 100 (3) (2020)
Guido Lancman, Alexander Coltoff, Amir Steinberg
Ruxolitinib for steroid-refractory graft-versus-host disease: A case series. Hematological oncology (2018)